Provided by Tiger Trade Technology Pte. Ltd.

Carpenter Technology

471.52
-4.9100-1.03%
Volume:488.46K
Turnover:229.97M
Market Cap:23.37B
PE:44.82
High:480.00
Open:478.22
Low:465.02
Close:476.43
52wk High:625.99
52wk Low:228.00
Shares:49.56M
Float Shares:48.15M
Volume Ratio:0.96
T/O Rate:1.01%
Dividend:0.80
Dividend Rate:0.17%
EPS(TTM):10.52
EPS(LYR):10.52
ROE:25.75%
ROA:11.87%
PB:10.49
PE(LYR):44.82

Loading ...

Carpenter Technology (CRS) Appoints Former CEO Tony Thene After Sudden Leadership Loss

Simply Wall St.
·
Jul 31

BHP Group Ltd Stock (BHP) Closed Up by 3.24% on Jul 30: What Investors Need To Know

TradingKey
·
Jul 31

Carpenter Technology Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Movement Alert|Carpenter Technology Falls 6.71% in Regular Trading, Q4 Revenue Misses Estimates Amid Sudden CEO Passing

Market Focus
·
Jul 30

Movement Alert|Carpenter Technology Falls 6.31% in Pre-Market Trading, Revenue Misses Estimates Despite EPS Beat Amid CEO Transition Uncertainty

Market Focus
·
Jul 30

Stock Track | Carpenter Technology Plunges 6.31% in Pre-market on Q4 Sales Miss Despite EPS Beat

Stock Track
·
Jul 30

Carpenter Technology Q4 FY26 EPS Rises 46% to $3.23; Net Sales Climb 13% to $851 Million

Reuters
·
Jul 30

Carpenter Technology Q4 Profit Beats on Higher Margins, Product Mix

Reuters
·
Jul 30

Carpenter Tech Q4 Adj. EPS $3.23 Beats $3.08 Estimate, Sales $851.000M Miss $863.367M Estimate

Benzinga Earnings
·
Jul 30

Carpenter Technology Reports Fourth Quarter and Fiscal Year 2026 Results

THOMSON REUTERS
·
Jul 30

Carpenter Technology Q4 EPS USD 3.23

THOMSON REUTERS
·
Jul 30

Carpenter Technology Corp: Expect to Generate $400 Mln to $430 Mln in Adjusted Free Cash Flow in Fiscal Year 2027

THOMSON REUTERS
·
Jul 30

Carpenter Technology Corp: for Q1 of Fiscal Year 2027, Anticipate Between $195 Mln to $200 Mln in Operating Income

THOMSON REUTERS
·
Jul 30

Carpenter Technology Corp: Set Medium-Term Target for Operating Income Between $1.2 Bln to $1.3 Bln in Fiscal Year 2029

THOMSON REUTERS
·
Jul 30

Movement Alert|Carpenter Technology Falls 6.65% in Regular Trading, CEO Sudden Passing Compounded by Sector-Wide Weakness

Market Focus
·
Jul 30

Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) as First-Line Consolidation Therapy for Large B-Cell Lymphoma

GlobeNewswire
·
Jul 29

Carpenter Technology Reinstates Former CEO After Sudden Loss

TIPRANKS
·
Jul 29

Movement Alert|Carpenter Technology Falls 5.11% in Regular Trading, CEO Brian Malloy Passes Away Suddenly

Market Focus
·
Jul 27

Carpenter Names Tony Thene CEO After Brian Malloy’s Death

Reuters
·
Jul 27

Carpenter Technology Corp - President and CEO Brian Malloy Passes Away

THOMSON REUTERS
·
Jul 27